[
    [
        {
            "time": "",
            "original_text": "晚报 宜宾地震为天然地震，非人工干预；双氢青蒿素片已在6家医院开展临床试验",
            "features": {
                "keywords": [
                    "宜宾地震",
                    "天然地震",
                    "双氢青蒿素",
                    "临床试验"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "晚报 宜宾地震为天然地震，非人工干预；双氢青蒿素片已在6家医院开展临床试验",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "瞄准女性“第一杀手”乳腺癌！友邦、微医、镁信联合发布首款单病险",
            "features": {
                "keywords": [
                    "乳腺癌",
                    "友邦",
                    "微医",
                    "镁信",
                    "单病险"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "保险",
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "瞄准女性“第一杀手”乳腺癌！友邦、微医、镁信联合发布首款单病险",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "誉衡药业逾期回复问询函：巨额商誉悬顶 超6成股份被质押 问询",
            "features": {
                "keywords": [
                    "誉衡药业",
                    "问询函",
                    "商誉",
                    "股份质押"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药",
                    "金融风险"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "誉衡药业逾期回复问询函：巨额商誉悬顶 超6成股份被质押 问询",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]